Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	240.92M
Revenue (ttm)	336.87M
Net Income (ttm)	6.38M
Shares Out	81.39M
EPS (ttm)	0.08
PE Ratio	37.48
Forward PE	16.44
Dividend	0.05 (1.66%)
Ex-Dividend Date	May 15, 2025

Volume	67,978
Average Volume	58,595
Open	2.950
Previous Close	2.960
Day's Range	2.910 - 3.000
52-Week Range	2.460 - 3.400
Beta	0.76
RSI	44.66
Earnings Date	Nov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,437
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.